BioStable Science & Engineering, Inc.
2621 Ridgepoint Drive
BioStable Science and Engineering: is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling surgeons to offer the recognized clinical benefits of valve repair to patients undergoing surgical correction of aortic insufficiency or aortic root aneurysm. Stable valve annuloplasty is universally recognized as the foundation of successful valve repair procedures. BioStable’s HAART Aortic Annuloplasty Devices are the first implants designed to provide rigid, three-dimensional stabilization of the complex anatomy of the aortic valve annulus. BioStable has completed extensive preclinical and clinical studies of it leading product, the HAART 300 Aortic Annuloplasty Device, and anticipates receiving CE Mark certification of this technology in 2016. To learn more about BioStable Science and Engineering, visit www.biostable-s-e.com.
CEO: John Wheeler
BioStable Science & Engineering